faers-gabapentin-pregabalin
Real public FDA reports
A Python pipeline on the four quarters of 2024 of FDA adverse event reports (1,480,549 reports after cleaning). It compares gabapentin and pregabalin for respiratory depression, with and without an opioid on the report.
Nine checks pass, including a second independent count and a re-run that gives an identical results file. Gabapentin against pregabalin: ROR 1.81 (95% CI 1.37 to 2.39).
Spontaneous reports from 2024 only, with no adjustment for age, sex, dose or illness. The opioid and no-opioid results cannot be told apart. A signal is a lead, not proof that a drug is related to an event.